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Previous stlldies have shown that caJclum oxalate (CaOx) stone-formers have 
lower urinary concentrations of myo-inositol hexakisphosphate (phytate or IPe) 
than healthy individuals, that dietary intake of this substance leads to its 
increased urinary excretion and that it is an inhibitor of CaOx nucleation and 
growth In South Africa it has been reported that the black population has a 
higher dietary phytate intake than whites. The present study was undertaken 
to test the hypothesis that South African black subjects have higher urinary 
phytate levels than their white cOLlflterparts and that this contributes to the 
relative rarity of caOx kidney stone disease in this population group 
A modified indirect extraction/photometry method to measure urinary IPe was 
designed, developed and tested in the present stlldy. This assay was then 
used to measure IPo in the urine of rural black and urban white subjects while 
on their free unrestricted diets In addition, urban black and white subjects 
each followed IPo-restricted followed by lPG-rich dietary protocols for a period 
of three days Urines were collected after administration of each protocol and 
were again analysed for IPe using the newly developed assay. Urines were 
then used in several crystallizatIOn experiments to measure the CaOx 
metastable limit, "C-oxalate deposition kinetics and inhiOition of CaOx crystal 
aggregation. 
The results showed that while on their free diets, rural blacks excreted 
significantly less IPs than urban whites despite their previously reported higher 
dietary intake of this substance This suggests that the renal handling of 
dietary IP~ is different in the two race groups Further evidence in support of 
this observation was obtained upon administration of the IP. -rich diet after 
which black subjects showed a higher uptake of IPe than their white 
counterparts and a statistically significant increase in urinary oxalate. Despite 
the important latter effect the tendency towards CaOx crystallization 
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Urinary stone disease IS amongst the oldest recognized medical disorders of 
mankind and has been acknowledged right through medical history (Drach 
1986; Ryall 1993). Stones can occur in the kidneys. ureters or bladder 
(Figure 1.11. The disease can be traced back 6680 years (Clari<.e 1968) and 
the symptoms have been known since ancient times (Grases el al 1998bl. 
Urinary stones can occur singly or in large numlJers. According to some 
hospital records in the Scandinavian countries. there has been an I.Ipsurge in 
the incidence of upper urinary tract stone disease in El.II"ope. North America 
and Japan since the lalter years of the 19,h century (Andersen 1966. 1969). 
Figure 1.1: Kidngy ston" lodged in the l1rete, of the l1rinary system (www.urosurye.ory) 
Between 1910 and 1960 a constant increase in the inCidence of renal stone 
was observed (Andersen 1966). However. the increase was interrupted twice 
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Heterogeneous nucleatiOll, secondary nucleation and epitaxy all take place 
before the metastable limit value is reacl1ed 
The possible condi tions urKier whicl1 CaOx nucleation can occur are 
illustrated in Figure 1 2 below 
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Figure 1.2: Rel~tiv., sup.,rsaturation and CaOx crystal nucleation. A: perfectly clear 
~qu .. ous solution of CaOx. B: Perfectly clear ~qu .. ous " oIution containing C~O. 











1.2.3 Crystal Growth 
Kidney stones can form by either growth or by aggregation of individual 
crystals. or by simultaneous growth and aggregation of small crystals into 
large particles of clinical~ signifICant size (Finlayson 1978. Fleisch 1978). 
Crystal growth is the process whereby new crystal components formed in 
urine add onto an already existing nucleus of a significant size The 
incorpora~on of new crystal components into a crystal lattICe is very 
complicated (Hess and Kok 1996) In order for crystal growth to occur, the 
newly formed crystal in the urine has to travel through the solutIOn and stick to 
the crystal. This process IS called bulk diffusion The surface reactIOn 
mechanism has been obselVed to be the one controlling the growth of COM 
crystals and therefore the hydrodynamic conditions in urine do not have any 
influence on its growth (Sohool and Grases 1995). 
1.2.4 Crystal Aggregation 
The process whereby crystals stick together to form a large particle is called 
aggregation. There are two kinds of aggregation mechanisms in kidney stone 
formation, namely primary and secondary aggregation (Sohnel and Grases 
1995) The former is a result of a crystal malgrowth that is found on the 
surface. Other crystals are then attached to this pre-existing crystal and form 
an aggregate (Hess and Kok 1996) In secondary aggregation, the free or 
independent particles suspended in solution collide with each other This is 
induced by Brownian motion of particles or shear forces acting in a liquid 
(Hess and Kok 1996) Colliding particles remain attached or can be 
separated by hydrodynamic forces, Resulting aggregates are composed of 
weakly oound, randomly orientated individual crystals and display a 
disordered structure which IS very different from the structure of particles 
formed by primary aggregation. Normal urine inhibits the aggregation of small 
caOx crystal (Fletcher ef al 1970). thereby suggesting that this is a normal 











If the crystalline saM dissolves then the process of aggregation is defeated 
and a stone cannot be formed via this mechallism. On the other halld, if the 
crystallille saM grows into a larger mass thell a stone is hkely to be formed. 
Once it starts, the process of aggregation is very quick (Robertson and Nordin 
1982) It can however be slowed doWIl by the repulsive zeta potelltial, This is 
the repulsive electrostatic surface charge that keeps the crystalline particles 
dlsaggregated (Hess and Kok 1996) III urolithiasis research, an incmase in 
the zeta potential is interpreted as an increase in the tendellcy to inhibit 
aggregatioll (Robertson and Scurr 1986). 
1.3 Inhibitors 
An inhibitor is any substallce, molecule, ion or agent tIlat retards any aspect 
(nucleation, growth or aggregation) of the crystallization of calcium salts in 
urine (Kok 1996. Ryall 1997) There have been several major reviews which 
descrilJe all aspects of structure, classifK;ation, mode of action in vitro and in 
vivo studies (Worcester 1996, Ryall 1997, Khall and Kok 2(04) 
Briefly. illhibltors can be classified into two major groups, Ilamely 
macromolecules (glycosaminoglycans and proteins) and micromolecules 
(citrate, magnesium, pyrophosphate. phosphOllates and phytate). 
1.3.1 Macromolecules 
Glycosaminoglycans (GAGs) 
GAGs are the most abll!ldant heteropolysaccharides (long unbranched 
polysaccharides containing a repeating disaccharide ullit) ill the body 
(wwwweb,indstate.edu). The most common GAGs include hyaluronic acid 
(HAl, dermatan sulphate. chondroitin sulphate (ChS). heparin. heparill 
sulphate and keratin sulphate. Among these, ChS is the most prevalent 
urinary GAG (Roberts alld Resnick 1986) Several GAGS, together with 
proteins are found in the organic matrix which constitutes 2 - 3% of the stOlle 











According to Ryall (1997), there is a lower concentration of GAGS in stone 
formers than in healthy individuals, This is of interest since different GAGs 
have been observed to affect different aspects of crystallization of CaOx and 
hence mhibit the formation of stones Crawford et 01 (1968) stated that 
heparin, ChS and HA are known to affect precipitation of CaOx GAGs, in 
particular ChS and heparin, are known to inhibit nucleation (KOOri et aI1989), 
growth (Robertson and Scurr 1986) and aggregation (Robertson and Scurr 
1986, Scurr and Robertson 1986) of CaOx in urine, Heparan sulphate on the 
other hand enhances CaOx crystal nucleation (Shum and Gohel 1993) and 
Inhibits aggregation (Suzuki and Ryall 1996) of CaOx crystallisation 
Urinary Proteins 
The role of urinary proteins in urOlithiasis has beell extensively investigated 
(Worcester 1994, Worcester 1996 Wesson el OIl 2000, Ryall 2004. Chauvet 
and Ryall 2005, Ryall el OIl 2005) Proteins are produced by renal epithelial 
cells and gain access to the urine by glomerular filtration (Worcester 1996) 
Several urinary proteins have been shown to be inhibitors of CaOx 
crystallization These include Tamm-Horsfall protein (THP), osteopontin 
(OPN), bikunin, nephrocalcin and urinary prothrombin fragment 1 (UPTF1) A 
brief description of these proteins is presented in the discussion below 
Tamm-Horsfall gtycoprolein (THP) 
THP is an addic urinary glycoprotein. It is the most abundant protein in 
human urine (Kumar and Muchmore 1990), Its urinary excretion is 20 to 200 
mg/d and has a monomeric molecular weight of 80000 daltons (RoDertson 
and Peacock 1983) Some studies have identified THP in the matrix of 
calcium stones (Doyle el af 1991). 
Studies using a spectrophotometric aggregation assay confirmed that THP is 
a potent inhibitor of crystal aggregation (Ryall et a11991) in a concentration 
dependent manner, inhibiting aggregation by 50'X, at a concentration of 10" 
mol/l and virtually 90% at 5 x 10" moVl (Hess e1011989) On the other hand. 
it has been reported that THP has almost no effect on growth or nucleation 












aggregation in undiluted. ultrafiltered urine (Ryall 1997) This is primarily 
achieved by sleric hindrance rather than adsorption to ttle sLXface of the 
crystal (Ryall 1997). Hess has postulated that THP in stone formers has a 
different molecular structure to that which occurs in normal healthy subjects 
(Hess 1991), 
In South Africa, studies involving THG from black and white candidates urine 
have shown that THG inhibits nucleation and aggregation and that the protein 
obtained from black subjects is a more potent inhibitor of CaOx crystallization 
than the one from white subjects (Craig et ,,/2001). However, matrix assisted 
laser desorption ionisation time of flight mass spectrometry (MALDI-TOF) and 
amino acid analysis and tryptic linger printHlg digestion demonstrated that 
there was no differellce in the composition of the protein (Craig el aI2000) 
Osteopontin (OPN) 
OPN is an acidiC urinary glycoprotein Its concentration in urine is 6 x 10" 
molll and it has a molecular weight of 32000 daltons (Worcester 1996). 
OPN has the ability to retard CaOx crystal growth and in supersaturated 
solutions it inhibits spontaneous nucleation (Worcester el 811992; Worcester 
and Beshensky 1995) as w~1 as heterogeneous nucleation of CaOx on 
apatite, In metastable solutions of calcium phosphate it inhibits 
hydroxyapatite crystal formation (Boskey 1995). Nishio et al (1999) reported 
that OPN is a strong inhibitor of CaOx growth It stereospecifically binds to 
the surface of the crystals thereby retarding growth (Ryall 1997). Another 
study reported that the potency of OPN is conferred by the protein's 
phosphorylation (Robertson and Peacock 1983) Because OPN contains a 
series of 8 to 11 aspartic acid residues, polyaspartic acid (PA) has also been 
included as a model inhibi tor in some crystallization studies as It exhibits 











Bikl1nin (Inter -(1-Trypsin Inhibitor) 
Inter-a-trypsin inhibitor is a proteoglycan containing a covalently bound 
glyscosaminoglycan side chain (Dawson ef aI1998)_ According to Dean ef al 
(2000), the true physiological concentration range is 6.25 - 18nmol/l Bikunin 
is the light chain of this larger proteoglycan and its molecular weight by SDS-
PAGE is 35000 daltons (Worcester 1996) The source of bikunin is not yet 
known but it is thought to be derived from serum by filtration at the 
glomerulus_ Bikunin is another glycoprotein found to have inhibitory activity 
with respect to CaOx crystal nucleation and growth (Atmani pi a/ 1993) 
Nephrocalcin (NC) 
NC is an anionic_ phosphorylated glycoprotein which contains between 2 and 
3 residues of 1 - carboxyglutamic acid (Gla) per molecule (Ryall 1997) Its 
urinary excretion is estimated to be in the range of 1 to 20 mg/d The 
monomeric molecular weight is approximately 14000 daltons (Worcester 
1996) 
NC inhibits growth of CaOx crystals in metastable supersaturated CaOx 
solutions in vitro (Worcester 1996) lis ability to inhibit crystal growth is 
believed to be through blockage of growth sites in the crystallatilce structure 
NC also inhibits CaOx crystal nucleation (Worcester 1996) As with most 
other macromolecules, inhibition of crystal aggregation appears to be related 
to changes in surface charges that occur when NC binds to crystals_ 
Urinary prothrombin fragment 1 (UPTF1) 
Initial reports showed that UPTFI was the principal component of caox 
urinary crystals (Doyle el al 1991) Its reported molecular mass is 31000 
daltons_ It is also present in calcium stones (Stapleton et al 1996)_ UPTFI 
concentration in urine only rises in response to lithogenic conditions (Ryall 
1997) It is known to inhibit both CaOx crystal growth and aggregation in 
undiluted, ultrafiltered human urine (Ryall el a11995, Webber of a12002) and 
its effect on CaOx crystal aggregalion depends on the concentration of the 












10 ,{-carboxyglutamic acid residues which birld Ca irl urirle (Grover arld Ryall 
2002) 
Irl recerlt studies, UPTF1 was isolated from the urirle of black and white South 
Africarl subjects and after being purified, its potency of inhibition of CaOx 
crystallization was tested in varioos crystallization experimerlts (Durrbaum el 
al 2001, Webber al aI2002) The results showed that there was quantitatively 
more UPTFI in the crystals in the urine of black candidates than that irl the 
white subjects and that UPTFI from black subjects' urirle was more potent 
than that from white subjects 
1.3.2 Micromolecules 
Citra/e 
Citrate is a potent inhibitor of all aspects of CaOx crystallisabon Citrate has 
been reported to retard the process of nucleation (Doremus el al 1978, 
Schwille el al 1999), growth (Ryall ct a/1981, Bek-Jensen el al 1996) and 
aggregation (Kok ct a11987, Tiselius ct .11 1993a and b) Citrate forms a 
soluble complex with calcium which reduces the concentration of free calcium 
in urine thereby reducing the risk of CaOx crystallization (Rodgers el a/2005) 
Citrate also binds to the surface of crystals and obstructs the attachment of 
the newly formed deposits ifl urine (Hallson ct al 1982, Ryall cl a/1985) 
Owing to its functionality, a number of citrate supplements are now used to 
remedy the disease These include potassium citrate (K-Cit) (Pak cI al1985 
Pak ct .11 1986, Whalley ct .11 1996), calcium sodium citrate (Ca-Na-Cit) 
(Schwille 1997), sodium potassium citrate (Na-K-Cit) (Schwille cf al1987 and 
Ogawa 1994) and potassium-magnesium Citrate (K-Mg-Cit) (Ettinger cI al 
1997). 
Magnesium 
Owing to Ihe competition between magnesium and calCium to bind oxalate. 
and to the fact that magnesium oxalate is more s~uble than CaOx (Hallsort et 












urinary magnesium levels (Lindberg ot al 199O). In vilro and in vivo studies 
conducted by Kohri et al (19SS), have demonstrated that magnesium IS an 
effective Inhibitor of both nucleation and growth of CaOx crystals 
Pyrophosphate 
Pyrophosphate is a strong Inhibitor of aggregation of CaOx crystals 
{Robertson ot at 1973, Robertson el 1111974, Felix et aI1977}. According to 
Ryall (1997). it also inhibits nucleanon, growth and a combination of growth 
and aggregation In an inorganic solution It inhibits these processes by 
binding calcium III its solid phase. Pyrophosphate preferentially and 
irreversibly binds to COM crystal surfaces and not COO {Shirane and Kagawa 
1993}. 
Phosphon11les 
These compounds are charactensed by P-C-P bonds One group known as 
the imidophosphates, however, has a P-N-P bond and has been reported to 
be a very effective inhibitor of CaOx crystallisation (Robertson and Fleisch 
1970), In addition. diphosphonates were also found to possess similar 
properties after being tested in a number of systems (Francis 1969: Ohata 
and Pak 1973; Pak 1976) 
It is the discovery of polyphosphates (Fleisch and Neuman 1961) and 
phosphorylated inositols (Thomas and Tilden 1972) that raised the possibility 
that other inorganic phosphate (Pi) molecules could also have CaOx 
crystallisation inhibitory capacity and hence be used therapeutically. One 
such molecule is myo-ioositol hexakisphospl1ate or phylate. Since this 
mOlecule is found in fibre-rich foods 'I>11lch have been known for a long time to 
be consumed by South African blacks while whites ingest refined foods, it is of 
particular interest in the context of the difference in stone incidence in South 













Phytate (IPs) is the salt of phytic acid (myo-inositol hexakisptlOSptlate) It is a 
substarlee of relatively low molecular weight (660 g/mol) and is present in 
blood. urine, intersti~al and intercellular fiuids (French ct .11 1991, BUrlee ct al 
1993, Grases and Llobera 1996, March et a/ 1998) Phytic acid is the 
prirleipal store of phosphate in plants such as beans and grams_ Rich sources 
include wheat oats, bran and flaxseed. which contain approximately 3% phytic 
acid (www_Phytochemicals,mfor)_ It constitutes 10 - 3Og/kg of the dry matter 
of cereal, legume and oilseeds and is the major portioo of the total 
ptlosphorus in the seeds of legumes (Burbano et a11995) 
Phytale interacts with basic amino acids, inhibi~ng a number of digestive 
enzymes (Reddy ct aI1982)_ During dlges~on in the human gut. phytic acid is 
enzymatically hydrolyzed by phytases to lower inositol phosphates such as 
inOSitol pentaphosphates {iPol inositol tetraphosphate (IP .), inositol 
triphosphate (IP3) and jXlssibly the di- and monoptlosphate (IP, and tP,) 
(Burbano et a/ 1995) It is not clear how much of IPs is freely soluble: 
however. its concentrahon is high in some cells (30 - 100j.Jmot/I (French ct a/ 
1991, Bunce ct a/1993)_ In plants. IP, has been identified as the immediate 
precursor of IP,) (Stephens and II"I/ine 1990, Brearley and Hanke 1996)_ It is 
not known whether a similar situation exists in animal cells. 
Some studies have demonstrated that phytate is also naturally present in 
human urine and normal levels range between 0,5 and 6,0 mgn (Grases and 
Llobera 1996, March et a11998) Of considerable interest in the context of 
urolithiasis is that the urinary concentration found in a group of active CaOx 
stone-formers was significantly lower than that of a group of healthy people 
(Grases ct a/2000a) It has been found that urinary phytate mainly depends 
on its dietary intake: when phytate is totally etiminated from the diet the 
urinary levels immediately fall and after several days become undetectable 
(Grases and Costa-Bauza 1999, Grases ct a/ 2000b) Ingeshon of phytate 
significantly reduces the risk of pathological calcifICations such as renal calculi 











A number of important beneficial effects of IPc, on human health have been 
noted It takes part in a number of im~rtant processes within the cell 
(Glennon and Shears 1993, Irvine 1995 Sasakawa e/ al 1995) IPc, is an 
important antioxidant (Hawkins et al 1993) protects against cancer 
(Shamsuddln 1995, Shamsuddin e/ a11997) and heart disease (Jariwalla et <II 
1990), and has hypocholesteroiemic effects (Trowell 1972, Trowell 1973) 
However. there is still some controversy and lIIlcertainty regarding the 
Diological role of phytic acid (Irvin 1995, Harland and Morris 1995. Sasakawa 
e/ a11995) According to Sandberg e/ 81 (1989) IPo (and IP,) has a negative 
effect on the bioavailability of minerals That is, it forms Insoluble (chelate) 
complexes with minerals such as Cu2', Zn2'. Fe", and Cal' (March et al 
1998), For this reason, IP" has long been considered an antinutrient (Grases 
et aI2001) This antinutrient effect. however is manfested only when large 
quantities of IP" are consumed in combination with an oligoelement diet 
(Cullumbine e/ a11950, Kelsay 1987. Sandstrom et a12000) 
1.4.1 Metabolism, Tissue Distribmion, Absorption and Excretion 
The metabolism of IPo was first studied by Sakamoto el 81 (1993)_ 
Radiolabelled IP6 was given to rats and it was observed that phytate was 
quickly absorbed by the stomach and distributed throughout the body to 
various tissues. Vucenik and Shamsuddin (1994) also reported that human 
malignant cells absorb and metabolize IPo_ 
Grases el <II (200Ob) carried out a similar study on two groups of Six male 
Wistar rats for a period of 100 days (7 phases) to study the relationship 
between oral ingestion (absorption) and urinary excretion of IP" One group 
served as the control and the other as the test group The control group fed 
on rat chow pellets for the duration of the study while the treated group was at 
first given an IPo free diet 24h urine samples were collected and analysed for 
IP6 every 3 - 5 days After observing a constantly lower IPo urinary 
concentration in the treated group, IP. was then adminstered to the rats in 
increasing amounts until a constant IP6 urinary concentration was attained_ 












IPs-rich diet, it eventually reached a peak excretiOO level which could not be 
exceeded despite the ingestion of additional quantities of IPo 
As a follow up on the rat study, Grases et al (2001) administered both an IPo" 
poor diet (IPs-PO) and an IPo-normal diet (IPo"NO) to a group of seven healthy 
volunteers during the first and second period of a pharmacoKinetic study 
Urinary levels of IPo were then determined during the two periods of study 
While following IP,,-PO and IP,,-NO for 15 and 16 days, respectively, urine 
samples were collected every day at 0, 2, 4, 6, 8 hours after an overnight fast 
to detennine the IPo urine content The results showed a dependence of IPo 
urinary concentration on its oral ingestiOO. The average concentratiOO of IPs 
determined while the candidates were following IPo-PO was lower than when 
the same subjects were on IPo-NO The urinary levels of [Po decreased to 
around 75 - 80% of the values normally found in humans after an IP,,"NO 
protocol. Both the disappearance and return of phytate to its normal LXinary 













The phytic acid molecule (Fig 1 3) coosists of 6 PO.,· groups. each of which 
is bonded to an oxygen atom which is itself bonded to a cyclohexane ring 
o , 
'0' 
Figure 1.3 Phytic acid structure (Johnson ~t aI1SSS) 
1.4.3 Inhibitory Activity Towards Stone Formation 
Phytate has been shown to be an inhibitor of caOx crystallization. This has 
been attributed to the affirlity of its phosphate groups for calcjum iOlls 
Furthermore. the ring structure of phytate causes significant disturbal"lCes 
(steric hindrance) of CaOx and calcium phosphate crystal nucleatioo and 
growth (Grases and Costa-Bauza 1999) through adsorption processes 
Several in vitro and in vivo studies 011 phytate have been carried and will be 
separately described in detail in the folloWing discussioo 
1.4.4 In Vitro Studies 
Because kidrley stOrle disease is a multifactorial disease. it has always been 
difficult to mimic the conditions that lead to the formation of stones in the 
kidneys However Grases and Costa-Bauza (1999) set up devices that 
simulated the conditioos closest to the ones in the kidneys in their study when 
analySing the potency of inhibition of growth of CaOx and CaJ(PO,:), by 
phytate In their study they monitored the growth of caOx and Ca3(PO.), on 
pig bladder epithe~al tissue ill the presellCe and absence of 1~g/ml IPo 












eliminate the effect of a heterogenous surface In the presence of IPs, a 
significant and total inhibition of caOx and Ca,(PO.h growth was observed 
On the other hand. when the study was conducted in the absence of phytate. 
the amount of crystals of CaOx and CaJ(pO.h was relatively higher. 
Grases and March (1989) investigated crystallization rates in the presence 
and absence of phytate in urine The rate of growth of CaOx crystals was 
high in the absence of phytate and phytate's inhibitory activity was observed 
to be pH dependent. In the presence of IP6 and at high pH, the inhibition of 
crystalline growth was significant However, when the negative charge on the 
moiecule was reduced by protonation (i.e at lower pH), inhibition decreased 
This can be ascribed to the neutralisation of the negative charge on phytate 
which would prevent its chelation to Ca?· . The inhibition of CaOx 
crystallization by IPs therefore depends on pH and its concentration. 
Chow cI ill (2004) used an in vitm model of stone growth to study the effect of 
phytate. The artificial lIine in which the stones were grown was 
supersatiiated with caOx and dosed wllh phytate At final concentrations of 
2.5 ~M and 5 ~M. stone growth was totally prevented. while at 0.5 ~M it was 
inhibited by 50% 
The effect of phytate on CaOx stone growth was again investigated in a 
subsequent study, in addition to its effect on Ca binding and. CaOx 
crystallization (Saw ct al 2005). IPs, when present at micro-molar 
concentrations similar to those found in urine, had a negligible effect on Ca in 
solution and had no observable effect on crystallization However CaOx 
stone growth inhibition was coniirmed at physiological concentrations of IPo 
The authors proposed that inhibition of stone growth is achieved through 
sunace effects since IP6 had no effect on solution calcium. 
A recent study showed that phytate enhances the potent effect of trace metals 
such as Fe" in the inhibition of CaOx crystallization (Munoz and Valiente 
2005) In their study. the authors prepared artificiat urine with some trace 












was compared in the presence of some urinary inhibitors such as phytate, 
pyrophosphate and Citrate. In addition to its ability to inhibit CaOx 
crystallization, Fe" inhibitory acbvity became even more enhanced in the 
presence of phytate and pyrophosphate than in the presence of citrate. This 
was attributed to the affinity of phytate for the CaOx crystal surface and its 
ability to form stable complexes with Ca", instead of Fe" in urine Citrate on 
the other hand, formed the complex with Fe", thereby nuilifying its inhibitory 
properties towards CaOx crystallization. 
1-4,5 Animal Studies 
Grases and Costa-Bauza (1999) administered ethylene glycol to induce CaOx 
crystalijsation and studied the effect of dietary phytate on urolith development 
in an animal model (Grases et aI1998a). Urinary phytate was determined in 
control and phytate-treated groups. At the end of the experiment, the kidneys 
were removed and macroscopically and microscopically examined for 
possible crystal or stone locations In the group of rats treated with phytate, 
the number of calcifications on the papillary tips and the total calCium in the 
papillary tissue were significantly reduced when compared with the control 
groups who were treated exclusively With ethylene gtycol, 
In another study Grases et al (2000c) fed female Wistar rats AIN-76A (rodent 
diet). There is a purified and non-punfied form of this food substance The 
former does not contain phytate while the latter does, In their study. Grases 
et .11 (2000c) divided these rats into three groups of 12 The first group was 
administered purified AIN-76A, the second group was given purified AIN-76A 
mixed with 1% phytate dodecasodium salt (1g of phytate per 100g 01 purified 
AIN-76A) while the last group was fed non-purified AIN-76A. The animals 
were fed for a period of 12 weeks. When the measurements on the urinary 
phytate content were performed, IPo could not De detected in the first group 
While the urinary phytate content in the second and third group was not 
significantly different, but signifN::antly higher than in the first group. 
Concentration of calcium and phosphate were also obselVed to be higher in 











the authors to conclude that absence of phytate in AIN·76A is one of the 
causes of the renal calcifICation in female rats 
1.4.6 Human Studies 
36 stone-formers (gender not stated) were employed in the study executed by 
Grases and Costa-Bauza (1999) 17 of the candidates were treated with 
phytic acid (120 mg/day) for 15 days while the other 19 served as tile control 
candidates At the end of the 15-day period, urine was collected and 
analysed It was demonstrated that deposits of CaOx and calcium poosphate 
did not form in the phytate-treated group thereby suggesting that the risk of 
stone formation was greatly reduced 
In another study. (Conte et al 1999), seventy-four active calcium oxalate 
stone·formers (gender not stated) were split into three groups of 19 (group 1) 
38 (group II) and 17 (group III) A lithogenic risk test for having calcium 
stones in the three groups of stO!1e-formers was carried out at baseline 
Thereafter, group I was not treated, group II was treated with potassium 
Citrate (6A8 Gm/day) and group III with phytate-rich diet (120 mg per day) 
After 15 days of treatment another lithogenic risk test was performed and it 
was observed that the risk for developing calcium stO!1es in groups II and III 
was greatly reduced. The risk was reduced in 7% of patie!lts in group I. 52% 
in group II and 50% in group III. 
When the COIlcentration of IP~ was measured in stO!1e-formers and healthy 
individuals (Grases et .11 2000a) it was observed that the stone-formers had 
lower urinary IPo COIlcentration In the light of these two studies (Conte et .11 
1999, Grases el al 2000a) it can be speculated that the lower urinary IPo 
concentrallOOIn the urine of the stone-formers is a possible contributory factor 
to renal stone disease and that dietary IPs may have the potential to be used 











1.5 Aims and Objectives 
As stated earlier. tt1e incidence of kidney stone disease in South African 
blacks is extremely rare while in tt1e white population it occurs witt1 a 
frequency of 10 -15% Dietary differences t1ave been considered as playing 
a role in this regard. TM black population·s diet consists mainly of fibre-nch 
food wh~e tt1at of the whites is more higt1ly refined (Modlin 1981) Since 
pIlytate occurs mainly in fibre-rict1 foods suct1 as oats it can be hypotMsized 
that the relatively higher dietary intake of this substance in the black group 
leads to relatively higher urinary concentration of pIlytate and hence 
contribute towards stone rarity in this group In order to test this hypothesis 
tM following objectives were defined 
i. to test published methods for their efficacy for urinary IP, analysis 
ii. to design. develop and test a more efficaciOlJs protocol. if necessary 
iii. to use the new protocol to measure free·diet urinary phytate 
concentration in rural black and urban white subjects 
Iv. to investigate the effeels on urinary phytate of low and high phytate 
dietary protocols in black and wt1ite urban o.ubjects with a view to 
establishing whether the two race groups have different handling 
mechanisms for this substance 
v. to investigate the effects on in vitro urinary CaOx crystallization 
processes of low and high phytate dietary protocols in black and white 
subjects with a view to establishing whether the retative risk of stone 
formatiOil in the two population groups manges as a consequence of 
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Many methods have been developed for the determination of IPo in foods 
(Talamond et 811998, Talamond el ai 2000). plants (Burbano el ai 1995) and 
biological samples such as plasma (March 131 a12oo1) artd urine (March el ai 
1998, Grases et ai 2000, March et a/ 2001, Grases 131 a12oo4) These are 
based on the colorimetric methoo of Heubner and Stadler (Holt 1955). In this 
method, IP6 IS extracted and then precipitated using ferric chloride (Davies 
and Reld 1979, Tangendjaja 131 ai 1980). The concentrallOn of IP~ is then 
determined by analysing phosphorus or iron in the preCipitate. Since these 
methods cannot distinguish between IP~ and other partially phosphorylated 
inositols, they are regarded as Inadequate This has led to the application of 
other advanced techniques such as hlgh performance liquid chromatography 
(Talamond et 1)/ 2000), inductively coupled plasma atomic emission 
spectroscopy (Grases el 8/2004) arod photometry (March el aI1998) 
A brief description of various techniques is given in the following paragraphs 
2.1.1 High Performance Liquid Chromatography (HPLC) 
This method is used in the direct determination of inOSitol (Perelo el a/2004). 
It is specifically designed for determination of IP6 in food (Talamond el al 
1998). As with most other methoos used to analyse IPo, a separation process 
is required before the actual detection is embarked upon. This is achieved by 
gradient elution OIl an 8IliOll exchange column using a conductivity detector 




















1I'Ir'II0000.th ....... is "'","""';::l1rn"'" 
1 


























































ImE)IICl:ltlOln tI"IAf"31tn'"A is some 
is a 































1 IrninoAII'1nn as 
1). 











Table 2.1: Assignment of 1H NMR spectrum of IP6 
ChemIcal Shift/a MultlpllClly J (Hz) '''sslgnmenl 
4.16 triplet 80 H1. H3. H5 
4.42 quartet 8.7 and 17.7 H4. H6 
4,85 broad doublet H2 
The equatorial ti2 prolon at a 4.85 is in the vicinity of axial H1 H3 and 
phosphorus (Pl. Owing to the equatorial/axial relationship between H1 and 
the H2 and H3 protons, two dooblets of the same frequency are produced 
However. in addition 10 these two douDiets, H2 cooples wIth "P to produce 
the broad doublet observed. H4 and H6, which are magnetically equIvalent 
are respectively adjacent to (H3, HS) and (Ht H5) as well as P. Both H4 and 
H6 are split into a quartet as they coople with two adjacent axial protons 
(J".ox) and P (JH.rl, 
The NMR assignments demonstrate that phytate is present in the 1 ax/5eq 
conformatIon as shown in Figure 2.1A. This is consistent with the 
conformation reported by Barrientos and Murthy (1996), in which IP" adopts 
this conformation at pH 0.5 - 9.0. This conformation orly changes to Sax/1eq 
when the pH is aiJove 9.0. The pH of the phytate solution used In the present 











Figure 2.4 iHustrates the complete 13C NMR spectrum of the phytate sample 
used in this study 
• i 
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The protOll·decOtipled llC NMR spectrum cOrltains four singlets which were 
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Figure 2.4: 'H - "c HSQC contour plot 
The two-dimerlsiorlal prolon - carllon correlation spectrum confirms that the 
protOrl triplet at M 2 results from protons attached to three carbons (C1 C3 
and C5), two of which are equivalent (C1, C3)_ 
Assignment of the carboo atoms in IP, is given il) Table 2.2 llelow_ 
Table 2.2: AsSlgl)ment of the "c NMR spectrum of phytate sample 
~- . . 
Chemical Shift/!i , Multiplicity Assignments 
73.5 singlet I C1 arnl C3 
75_5 singlet C2 
~ ~ ---- -
76.2 singlet C4 and C6 











The chemical shift of the equivalent carbon atoms Cl and C3 is different from 
the other equivalent pair C4 and C6 (refer to Figure 2.1 for numbering) Both 
Cl and C3 are adjacent to an a)(ial P at C2, whereas C6 and C4 are adjacent 
to an equatorial P on C5. This results in greater deshlelding 01 Cl and C3 than 
C4 and C6 whICh renders the two pairs of carbon atoms non-equivalent and 
explains why they resonate at differeni Chemical shift values (Costello ct al 
1976)_ 
The J'p NMR spectrum olIP~ used in this study together With the assignments 
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Figure 2_5: Phosphorus (,'P) NMR spectrum of phyt.ate used in this study 
The ~.,p spectrum oblall1W in the present study shows an apparent doublet 
that appears at 3_00 ppm Even though the above spectrum appears to be a 
doublet, it is probably a quartet where overlapping of 2 signals (indicated by 
arrows) has occurred This proposal is supported by the observatlOn made by 
Costello cl al (1976)_ 
WIlen Costello and co-workers used Jlp NMR to study the properties of 












Jlp NMR spectra differed coosiderably in position and appearance This 
suggested that p/1ytate J1p NMR might be the sensitive to the medium used 
when cooducting the study_ It was subsequently shown that the appearance 
of the lip NMR spectra differed with the iOOs cootamed in the medium 
Therefore. in order to validate the comparison counter·iOlls present in the 
medium should also be taken into consideration 
Since sodium hexakisphosp/1ate (myoinositol) was used in the present study. 
the effect of the counter ion sodium must be considered When sodium is the 
counter·ion two differences are observed. 
The chemical shift values resonate at fields lower than those in the 
presence of other counter ions such as ammonium 
The individual signals are grouped more tightly and hence there 
appears to be a small difference in the cI1emical shift values leading 
to overlap of the signals (Costello et a/1976)_ 
An example of :)'P NMR spectrum of myoinositol hexakisp/1osp/1ate with 
sodium as the counter·catiOO in the pH range of 4· 10 is Shown in Figure 2,6 



























fig. 2.6: "P NMR of IP. in the presence of sodium as the counter-ion 
(Costello ,,' al 1976) 
The down field signal is due to P at C2 (deshielded) and the high field one is 
due to C5 P (shielded equatorial) (Johnson and Tate 1969). 
The six P groups are dependent on the pH and ionic strength of the solvent, in 
particular (Cl and C3) and (C4 and CB). The signal pertaining to Cl and C3 
was observed to be most affected by ionic strength and least by pH On the 
contrary. C4 and C6 Signal was affected mostly by pH and least by ionic 
strength The two other signals due to P at C2 and CS were least affected by 
changes in the ionic strength and pH (Costello et a11976) 
Owing to the above-mentioned reasons, it is concluded that what appears to 












the ratio of 1 221. Tr.e two "P resonance signals due to P at C2 and C5 are 
not clearty resolved 
"P is a very useful technique to analyse phosphates. However in this case 
there was severe signal overlap making the analysis difficujt A solution to this 
problem would be to use lanthanide shift reagent but it was not availab~ ~ the 
present study 
Conclusion 
All the three spectra (' H, '-'C, "P) and 'H - "c NMR (CO(ltour plot) obtained in 
tr.e present study supported the previously puohshed analysis and 
assignments of IP6 This confirms the identity of the sample characterised as 
IP6 and indicates that It is found III the sterically staole conformation with 1 
ax/Seq phosphoric acid groups. 
2.2.3 Ion Chromatography 
Introduction 
The purpose of this experiment was to identify ions (impurities) that might be 
contaminating the commerciallP6 salt solution The method was used also to 
proVide quantitative analysis of these anions. 
Method 
IP6 salt was dissolved in water to give a solution of concentration 100ppm. 
The solution was then passed once through Millipore filters (0.45jJm) to 
remove partiCLMate matter. 
Samples were analysed by high performance anion exchange 
chromatography (HPAEC) using a DIONEX BiolC system. This system was 
coupled with AS50 autosampler. lC30 oven, EG50 eluent generator, GS50 
gradient pump ED50 electrochemical detector (conductiVity mode) and 
chromelian software. The operating conditiO(ls were as follows: 
Column: Ion Pac ASI1-HC (2mm x 25Omm) analyticaj column and 












The flow rate was 038 mllmirl and the total rUrl time was 18 min 
Eluent Gradierlt elution lOmM· 75mM NaOH 
Conductivity detection with suppression (suppressor current 100 
rnA) 
Sample loop 25 1-11 
Results and Discussion 
The chromatographs (Figure 2.?) show phytic acid standard solutions of 
increasing cOl1Centrations. The peaks corresponding to PO.'- and IP6 are 
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The peaks between 2 and 6 minutes represent ions from the solvent (MllliQ 
water) used because these peaks appear when water is run alone, The 
identified ones include sulphate, fluoride, chloride. nitrite, bromide and ni trate 
(identified by comparison with standards of sulphate fl uoride), (Since MilliQ 
water has high purity, the impurities could have come from the columns or the 
glassware used) Phosphate ions are present in the phytic acid standard 











increase in area is the one representative of the dodeca-anion of phytic acid 
(12 min). The ~ze of phosphate peaks in Figure 2.7 can De said to be 
surprising in the sense that it differs in different standard solutions. Its 
concentration does oot increase with the increase in the concentratIOn of IPe 
salt 
Figure 2.8 shows the chromatogram of ions contained in a given phytic acid 
standard solu tion. The height of the peak is prorx>rtional to the concentration 
of the respective ion 
Figurft 2.8: Chromatogram of i""s contain .... in a gi~ .. n 
phytate standard solution 




Peaks between 2·6 minutes are ions from the solvent (water) Peak at 12.3 
minute is phytic acid. Smaller peaks In the same region are probably due to 
phytic acid isomers. The peak at 8.37 is for the free phosphate ion. 
Conclusion 
Since the intensity of the impurities does oot increase linearly with 
concentration of phytate (Figure 2.7), it is then conCluded that contamination 














The hydrolysis experiment was used to determine the percentage composition 
of tPo in a given tP, salt solution by quantifying the PO.)· liberated after IP6 
hydrolysis. Myo--inositol hexakisphosphate can be converted to myo-inositol 
by heating the molecule in an acidic medium Six phosphate ions are 









Figurn 2.9: HydrolY"is of IP, to myo-inositol and phoephat .. 
When a molybdate solution is added to thiS mixture (i.e. myo-inositol and 
phosphate ions), a phosphomolybdic acid complex (yellow) is formed. This 
complex can be reduced further by addition of Srlel, The product that results 












Figure 2.10 Slructure of phosphomolybdocomplex (www ... ci~nc ... csumb ... du) 
The intensity of the resulting blue sootion can De used to measure the 
concentration of phosphate spectrophotometrica"y. Absorbance is measured 
at 715nm and is directly proportional to cOIlcentratiOll in accordance with 
Beer-LamDert's Law 
This method has not only been used to measure the concentration of 
phosphate, but has atso tleen used to determine indirectly the concentration 
of other phosphate-containing molecules such as IPo 
Method 
In order to determine the optimum number of cycles required to ensure 
complete hydrolysis of phytale, eight 10-ml PTFE vials containing 2.6ml of 
2.5mgJl phytate were healed in a microwave (850W) Vials 1 and 2 were 
removed after 7 cycles of 2.5 min each, vials 3 and 4 after nine cycles. vials 5 
and 6 after 12 cycles and the last two were removed after 15 cycles. All the 
vials were then allowed to cool to room temperature and phosphate was 
determined in each. After measuring the absorbance of the extracted organic 
solutions, a graph of absorbance versus the number of cycles was plotted 
Results and Discussion 
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Figurv 2.11: The mean absorbaoce values of PO." solutions aft .. , hydrolysis of an IP, 
5tl1ndar<:l solution 
According to the graph, there was virtualJy no free phosphate detected in the 
unhydrolysed solution (0 cycles), After seven cycles of hydrolysis. the 
phosphate coocentration was very low as indicated by the very low 
absorbance value A sharp increase in phosphate corleentration was 
observed after seven cycles. When the number of hydrolysis cycles was 
increased to 12 oot much c1lffereflOO was noted in the absorbance 
Absorbance values tended towards a plateau thereafter 
Conclusion 
Following the observation made in Figure 11. it was cor1Cluded that 12 cycles 
would be sufficient to hydrolyse pIlytic acid to myo-inositol and 6 PO.3-
However. even though there was a negligible increase in absorbance when 
the hydrolysis was performed for 15 cydes, the latter was decided to be the 
optimum nLiffiber of cycles to be Llsed in order to ensure thorough IP" 
hydrolysis 
2.2.5 Hydrolysis of Commercial/P. Salt for Purity Investigation 
Five milligrams of IPe salt was dissolved in 1 litre of water. An aliqoot of 
volume 2.6ml of this stClildard solution was hydrolysed by heating in a 












cycles of 2.5 min each The vials were allowed to cool for 20 min between 
cycles to avoid overheating After the fifteenth cycle the sample was allowed 
to cool to room temperature and phosphate was determined as described 
below (phosphate determination experiment) 
Phosphate Determination 
The assay described by March el81 (1998) was used in this study. A standard 
curve was constructed using cOrleentrations of 0.0. 0.5. 1,0. 1 5. 2.0, 25, 3.0, 
4.0, 50, 7.0 mg/l solutions of commerCial phytate These were hydrolysed for 
15 cycles of 2.5 min each and were treated as described below. The 
absorbance of phosphate ions liberated from phytate in each aliquot was 
measured and plotted against concentration, 
Two millilitres of PO." contalnirlg solution was removed from the PTFE vial 
and 0.8 ml of O.03M ammonium molybdate ((NH.",M070,.4H,O) and 0.2 ml 
of 92 mM SnCI, were added, After 20 min. 1.8 ml of 1.6 gIl Adogen 464 
(Sigma-Aldrich, Germany) in ethyl acetate was added to extract the 
phosphomolybdate complex formed. Addition cJ the extractant resulted in the 
formation of two phases The top, organic layer was separated from the 
aqueous bottom layer using a Gilson pipette and the absorbance was 
measured at 715nm using a UV-spectropholomer (Speclronic Unicam). The 
absorbance readirlg obtained was then used to determine the concentration of 
IP, from the calibration curve of absorbance versus phytate concentration 
This experimentally determined value for the concentration of IPs was then 
compared to the theoretical one and the percentage composition of the 
commerciallPo was calculated The experiment was performed in duplicate, 
Results and Discussion 
The commercial IP, salt was used in the present study to prepare standard 
sok.itions of IP" The formula of the salt is C,H'202<PoNa, and its molar mass 
is 792 g/mol. When solutions of the salt are prepared it dissociates irtto 6H+ 











is 648 g/mol, the theoretical perc;erltage of pIlytate ion in the commercial 
phytic acid salt is 81.8% The experimentally determined percentage 
compositiorl value is shown in Table 2.3 
Table 2.3: Hydrolysis experiment 
The difference between the theoretical value of 81 8% al"ld the experimentally 
determined value of 75.8% is likely due to the presence of phosphate, 
sulphate, fiuoride, chloride, nitrite. bromide al"ld nitrate aniOI"lS which were 
detected by iOI"l chromatography in the present study This percel"ltage 
composition would then be taken mto GOrlsideratiol"l when all the relevant 
calculations are made 
Conclusion 
The dodeca-al"liol"l of phytic acid cOl"lstitutes 75.8% of the saWs mass used in 
any experimel"lt 
2.3 Test of the Accuracy of Indirect Extraction/Photometry Method 
2.3.1 Phosphate Calibration Curve 
Introduction 
Phosphate COl"lCentration can be measured in solution using ammonium 
molybdate as described earlier The aim of carrying out this experiment was to 
determine whether the absorbance of phosphate solutions is directly 
proportional to the phosphate concerltratlOn and hence, whether this method 













Phosphate standard sojutions of concentration 0.0, 3.0, 60, g.O, 12.0, 18,0. 
30,0 and 42.0 mgn were prepared using di-sodium hydrogen phosphate 
{Na2HPO.} (monobasic) in MilliQ water. The phosphate concentration of each 
standard was determined in duplicate as described above {phosphate 
determination experiment} A graph of the average absorbance value for 
each standard was plotted against concentration. 
Results and Discussion 
Figure 2.12 shows the calibration curve obtained for the determination of 
phosphate 
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Figur~ 2.12: Phosphat~ c~lIbr.tk>n curv~ p"'p;ir~d usi"g st;"'d~n;I phosphate 
solutions 
Conclusion 
The absorbance increased linearly with the phosphate concentration, This 
demonstrates that the determination of PO.'- {and hence IPo} using the 
method described would be senSitive and accurate 
However, it is necessary to be wary of the fact that urine contains many 












that this contaminatioo may influence the conOOlltration of IPs detected by this 
method 
2.3.2 IP. Calibration Curves 
Introduction 
The first step was to measure the absorbance of the free phosphate in the 
urlllydrolysed 1P6 standard solutions The second step was to hydrolyse 
aliquots of the same standards. measure the absorbance and draw a 
calibration curve. The final step was to use the calibration curve to measure 
the concentration of IPe. in urine after hydrolysis. 
Method 
Non-hydrolysed IP. 
IPe. standards (D.O. 0.5. 1 D. 1 5. 20. 3.0, 5.0. 7.0 mgll) were prepared using 
the commercial sodium salt of IP •. 2.0ml was withdrawn from each solution 
and the phosphate cOrlCentration was determined as previously described 
(phosphate determination experiment) The experiment was performed in 
duplicate A standard calibratJon curve was constructed by plottirog average 
absorbance values against concentrabon 
Hydrolysed IPi; 
2.6ml of each IPs standard olutioo was Plpetted into a 10ml PTFE vial. These 
were heated in a microwave oven for fifteen cycles of 2.5min each After 
allowiflg the vials to cool to room temperature. phosphate was determined 
(phosphate determination experiment) The experiment was performed in 
duplicate. A standard calibralioo curve was constructed by plottlflg the 












Results and Discussion 
Phytllte (Unhydrolysed) Clllibmlion CliNe 
Figure 2 13 shows the absorbance of the free phosphate ion contained in 
commercial phytate 
'" 
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Figure 2.13: Phyt.1te c~libr~tion curve prep~red using unhydrolysed phyt.1te standard 
solutions. 
The graph demonstrates there was a variation in the content of free 
phosphate in the different phytate standard solutions However. all of the 
absorbances were very low The expected PO.,· absorbance in all standards 
was zero if IP" was pure. but the result in Figure 2.11 indicates that the 
commercial phytate contains a small amount of free phosphate. This result 
supports the observation made in Figure 2.7 where the amount of PO.,· 












Pilytatc Hydrolyscd Calibration CUNC 
Figure 2.14 shows absorbance of phosphate ioos in solutions of various 




y - U.3Ul on _ U.Zl!j.j 
It' _ '.%9 
Figure 2.1<1: Pttytale calibraliO<1 cur"Ye I'repared using hydrolysed phytate sland~rd 
solutiO<1s 
As expected, the graph shows a lir!ear increase in the mean absorbance 
values as the concentration of the hydrolysed phytate IS increased Therefore 
the aliquots after hydrolysis had different cOllcentratlons of phosphate ioos. 
On the other hand, a negative absorbance would indicate total absence of 
phosphate ions (hence phytate) in solutiOll 
Conclusion 
The melJ10d is sensitive to free phosphate only, In order to accurately 
determine IPo concentration USing PO.", IPo should be fully hydrolysed as no 
bound PO,'- groups would be detected by the method 
2.4 Anion Exchange Chromatography 
Introduction 
When an eluent is applied onto a stationery phase (resin), the ions in the 
eluent are adsorbed onto the surface of the reSin, If the surface of the resin is 
positively charged (anion exchange column) then all the oppOSitely charged 
ions in the eluent are attracted while the ions with a similar charge are eluted. 












force with which they are held to the resin depends on the charge they bear 
1 mole of dodeca-anion of pIly11C acid has a charge of 18- whilst POo"- has a 
charge of 3- This would result in some IPo-ion Deir'lg strortgly Dour'ld while 
PO.'- is weakly bound to the reSin. With time, the weakly bound ions are 
eluted by the mobile pIlase from the columr'l followed by the stror'lgly retained 
Ions. ThiS property has been used to separate ior'ls contamed in a solution 
and is the pnr'ICiple of ar'lior'l eXchartge chromatography 
Method 
The reSin used in these experiments was an anion exchange Dowex 1 x 8; 
200 - 400 mesh CI, supplied by Sigma-Aldrich Before packirtg the column, 
the resin was dried in an oven for 3 days at 27aC until It was free-flowmg 
(Vogel 1978) 1 5g of the resin was then weighed and used to form a slurry 
(mixed with 25 ml 0.05M HCI) that was added to a columr'l packed With cotton 
wool at the bottom Care was taken to ensure that no trapping of air buDbles 
or channelling occurred 2 ml HCI covered the top of the resin bed to prevent 
drying 
MilliQ water was used as a solvent in all the water-based solutions. HCI was 
used to wash out PO.'" ions from the column (O.4mllmin flow rate). H,S04 
(O.2m1lmin flow rate) was used to elute the more strongly retained IPs. A 
peristaltic pump was used to control the fiow rate of the column 
Two approaches towards the effective separation and elubon of IP. from the 
anion exchartge column were tested. 
1 Use of a high concentration of HCI to elute the retained poi ions from 
the column as quickly as possible while retaining the bound IPo. 
Use of a high concentration of H,SO. for the efficient elution of IPs from 
the column 
The optimal HCI and H2S04 cOr'lcentrations and volumes were 











2 Use of a low coocentrabon of both HCI and H2SO. as cited by March et 
;)1 (1998). 
2.4.1 Determination of Optimal HCI Concentration Required to Elute 
pol-
A phosphate solution of concentration 1.0 gil (approximate concentration of 
PO.3 in urine) was prepared by dissolving di-sodium hydrogen phosphate 
(Na2HPO.) in water Aliquots (5 ml) of this solu\lon were applied to six anion 
exchange columns. SOmI of HCI standard solutions (0.30. 0.35. and 04OM) 
were passed through columns 1 to 3 respectively in order to elute the retained 
PO.' The final Sml of the 50ml eluants was collected Aliquots (2ml) of the 
latter were used for the determinabon of PO.'- (phosphate determination 
experiment) The experiment was repeated in columns 4 - 6. A plot of 
absorbance versus HCI concentration was constructed {Fig, 2, 16} 
It has been reported that the molybdenum oxides (MoO] and MoO;) can be 
reduced in HCI to form [MoOCl,f (reactions 1 and 2 below) (Cotton and 
Wilkinson 1980), When a suspension of these molybderlllm oxides is treated 
with reducing agents such as stannous (Sn") ions an intense blue colour is 
achieved (www,rsc.orglchemcomm) 
\Nnen the highest concentration of HCI was used, more of these oxides were 
reduced making the already blue phosphomolybdate colour even more 
intense This will have interfered with the study. 
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Results and Discussion 
The average absorbance values of p/losphate obtained after elution of PO,';-
from the column using different concentrations of HCI are shown in Figure 
2.15. When the trendline was extrapolated to the abscissa, an optimal (lowest 
concentration of HClthat can be used to elute all the free phosptlate from the 
column) concentration of O.2M HCI was determined (Figure 2 15) 
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Figure 2.15: Plot of average abs rbance vs concentration of HCI for the 
det .. rmination of optimum HCi con~~ntration required to elute ro t 
Conclusion 
Following the observabon from Figure 2.15 the optimum concentration of HCI 
to be used is O.2M 
2.4.2 Determination of Optimal Volume of Hel Required to Elute PO/-
Five millilitres of phosphate solution of concentration 1 0 gil was applied to 
eight anion exchange columns. Different volumes of O.20M HCI (optimum HCI 
concentration required to elute PO,') were then passed through each column: 
namely 10, 15,20. and 25ml Duplicate aliquots of 2ml each were removed 











determined (phosphate determination experiment). A graph of absorbance 
versus volume was plotted 
Results and Discussion 
Figure 216 shows the experimental results to determine the optimum O,2M 
HCI volume used to elute PO.'- from the columl1 
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FigUTe 2.16; Plot of average absorbance vs volume of O.2M Hel 
The trendlil1e crosses the x-axis at a volume of 24 26m1 Thus this is the 
volume of HCI that was required to elute all phosphate ions from the column 
Represel1ted in tabular form (Table 2.4), the absorbance after passil1g 25ml 
was found to be ---017 This shows that there were no phosphate ions 
retail1ed by the coIuml1. 
Table 2.4: Determination of optimal volume of O.2M Hel 
















The volume of O.2M HCI to be used to elute PO." from the column is 24.26 
ml This volume was approximated to 24.3 ml 
2.4.3 Determination of Optimal H2SO. Concentration Required to Elute 
IP, 
Sulphuric acid standard solutions of concentrations 2.5, 3.0, 3.5 and 4.0M 
were prepared Eight anioo exchange columns were set up. Five millilitres of 
a phytate solution (5.0 mgn) was loaded onto each cotumn and the eluate 
(first fractiOl1) from each was discarded 24.3 ml of O.20M Hel solution 
(optimal volume and concentratIOns determined above) was then applied to 
each column The flow through (2"0 fracbon) from each column was again 
discarded. Finally, 5ml of each concentration of H,SO. was apptied to 
dupticate columns and the eluants (3'0 fracllon) were collected 
The 3'0 fractions from dupticate columns were mixed and vortexed From the 
resulting 10ml solution from each pair, two 2.6ml allquots were withdrawn and 
placed in two 1 ami PTFE vials. These vials were heated in a microwave for 15 
cycles of 2.5min each. After allowing the vials to coot to room temperature 
phosphate was determined in each (phosphate determination experiment) 
The absorbance values at each concentration of H,SO. were then averaged 
and plotted against concentration 
Results and Discussion 
Figure 2.17 shows the plot of absorbance as a function of the concentration of 
H,SO. which was used to determine the optimum acid concentration required 
to elute the strongly bound phytate from the column The trendline crosses the 
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Figure 2.17: Absorb<once as a function ofth .. H,SO. conc .. nt .... tion 
Conclusion 
4M H,SO. is the optimal concentration that should be used to elute the 
strOrlgly bound IPo from the anion exchange resin. 
2.4.4 IP. Standard Solution Application 
The efficiency of the derived volume and concentration of Hel and H2 SO, 
solutions was tested 5 ml of a 6.25 mglllP6 sail solutioo was loaded onto the 
column The first fractlOO was then collected. 24.3 ml of O.2M Hel was 
applied OIlto the column and the eluate was Collected. Laslly, 5 ml of 4M 
H2 SO, was loaded and the fiow through was collected All three fractions 
were then hydrolysed and phosphate was determined (phosphate 
determlnatiOll expenment) and hence IPo concentration determined 
Results and Discussion 
Table 2.5 &lows the composition of the three fractioos collected after applying 












Table 2.5: IPc, concentrations in the three eluates collected after IP, 
application 
~e·-Ij •. " , iii _"PO~"''''''''' ~",pr: 
. ," .• ~15n r1t ':' 1(m.. . 
-;.; ~,c"~mp~~~1IJ 
"' ,~ 
~.I' , .-' " Theoretical Actu~~J "- .,,-' , ~"'~3~~\''''''. ~ - "' -"'" 
1 0.044 0.905 
2 0.236 1 54 
3 0.753 3.25 52.0 68.6 
• Dtffereoce tn mean absorl1aoce of phosphate ton tn h~drol~s"d ~nd unh~drolys .. d 
sample 
Of the three eluates. the third one is the most important Eluate 1 shOlild 
contain a minimal amount of phytate ion or be free of IPs and the second one 
should contain impurities separated from IPc, The third fraction is the one 
expected to elute retained IP6 from the column. The amount of IPc, that is 
eluted in the third eluate is therefore divided by the amount applied onto Ihe 
column to calculate percentage composition 
Considering eluate 3 only, the percentage composition of IPo was: 
(32516.25) x 100 
= 52'10 





The percentage yield of 68.6 is low. The effluents (HCI and H2 S04) used did 
not efficiently separate PO.o from IPo Phytate must have been neutralized 












and was not retained in the column. Therefore these concentrations cannot De 
used in the quantitative determination of IP6 in urioo 
2.4.5 Testing the Separation and Elution of PO.l- and IP. at Urinary 
Concentrations 
The objective was to test whether the empirically determiood optimum 
concentrations arxJ volumes of HCI arxJ H?SO. would effectively separate 
PO.'- from IP6 as well as elute IP, from the column when the laller two 
COmfX1nents are applied at their L1finary concentrations 5.0 ml of P04'-
solution (2.0 gil) was mixed with 5.0 ml of IPs solution (to mgJl). The fllal 
COllCentratlOllS of PO."- and IPo solutioos were t gil and 5 mgJl. respectively 
(approximate concentrations of PO.'- and IPs in healthy individuals' urine 
(Grases et ,112004)) 
5 ml of the mixture was applied to each of two identical anion exchange 
columns followed by 24.3 ml of 0.20 M HCI (optimal volume and 
concentration). Finally, 5 ml of 4M H,SO. (optimal concentration) was applied 
to each column to elute the strongly retained IPs from the reSin. 
In order to mOnitor the progress of IP5 through the columns, tM first. second 
and the third fractions were collected All 3 fractions were treated as above 
(Optimal H,SO. concentration required to elute IP6) IPo was also determined 
in each fraction (phosphate determinatiorl experimerlt) and thus the 
percerltage ComPOSltlOll of IPe irl each fraction could De calculated The 
experiment was performed m duplicate 
Results and Discussion 
Table 2.6 below gives details of the Coocentration of IP~ determined in each 












Table 2.6: Application olIP~ and Na,HPO. mixture onto the anion exchange 
column 











1 84 36.8 




As stated earlier, commercial IP6 sail only contains 75,8 IP" therefore the 
actual recovery is 
36.8/0.758 
= 48,5% 
A possible explanalion lor Ihe observed high concenlration ollPt eluted in the 
first fraction Is that the phytic acid amon might have become prolonated by the 
highly concenlrOited Hel (2.0M) that was used 10 prepare the c~umn This 
would hOlve neutralised the IP" Ion thereby preventing It from being retained 
by the positively charged resin 
Conclusion 
With regard 10 the amount of IP6eluted in the second eluent (Table 2.6) it is 
seen that 24,3ml O,2M Hel failed to separate PO.,· from phytic add. A large 
amount of IP" was eluted with PO." indicating that O.2M Hel is not suitOible 
In view 01 the observed low percentage yields obtained an OIlternative method 
was tested Lower concentrations 01 Hel and H1SO., namely O,OSM and 2M 












2.4.6 Use of Lower HCI and Lower H2SO. Concentrations (March et al 
1998) 
Determination of HCI Volume 
Sml phosphate standard solu tion (I agn) was applied to 7 columns. 
Thereafter IS. 20. 2S, 3D, 3S, 40 or SOml aliquots of a O,OSOM Hel solution 
were applfed individually to these columns to elute the retained PO.'- In 
order to determine whether all PO.3 eluted efficiently. Sml of 2,0 M H2 SO< 
was applied to eacl1 column Immediately after HC!. The 3 fractions collected 
from each column were tested for the presence of PO."- (phosphate 
determination experiment) and the absorbance values were recorded. The 
experiment was repeated in columns 8 - 14 i,e. it was performed in duplicate 
Results and Discussion 
The results of the study in which different volumes of O.OSM Hel were used to 
elute 19/1 PO." from colLrnn are shown in Table 2.7. The lowest absorbance 
in the 3'" fraction indicates the amount of O.OSM HCI that effectively elutes 
free phosphate from the column 
Table 2.7: Absorption values for phosphate eluted in fraction 3 after 
application of various volumes of O,05M Hel 




















From table 2.7 It can be seen that 50ml of Hel eluted all the PO.3- that had 
been initially retained by the column 
2.4.7 pol' Application onto the Column 
In order to test whether the derived volume would effect separation of PO/-
from IPs using an anion exchange column,S ml of 1 gil PO.,,· standard 
solution was applied onto the column. The fiow through was cOllected. This 
was followed by application of 50 ml of 0,05M He!. The second fraction was 
collected and subsequently, 2M H2S04 was loaded onto the column and the 
third eluate was collected The three fractions were all analysed for PO. ' -
(phosphate determination experiment) and the percentage composi tion was 
calculated. 
Results and Discussion 
Table 2.8 shows the various phosphate concentrations contained in the 
fractions collected from the column. 
Table 2.B: Recovery of P04 '- after application of 1911 PO. ,· standard solution 
onto the column 
"Eluate Abs (f1!nm) PO.'" (mwl) % 
Composition 
1 2.23 48.7 
2 4.05 904 
3 *Low ~ 95.3 











From the equatioo of the standard callbratiorl curve (Figure 2.12): 
- 0 1001 " 0.0437x 
x (coocerrtratioo) "48.7 
In the same way, 4.0S - 0.1 001 = 0.048x 
x = 90,39 
Sirlce the secood eluerrt was diluted SO times by the HCI (hence dilutlOrl factor 
=10) then 
90.39 x 10" 903.9 
The amount of PO.'- recovered is therefore, 903.9 + 48.7 = 9S2.6mg 
In terms of percentage 952 6/1000 x 100= 95.3 % 
The first fraction (i.e the fiow through) carltained 48.7 mg/I PO/' The 
majority of the phosphate was eluted from the columrr by O.OSM HCI In the 
third eluate. the corrcentratiorr of PO.'- was v ry low. The percentage 
compasitiOrl was 95.3%. 
Conclusion 
50 ml 0,05M HCI efficiently elutes PO. ,- from the anion excharlge resin, 
2A.8 IP. Standard Solution Application 
After determining the optimal volume of 0050M HCI required to elute all of the 
PO.3. 5ml of S.omgIlIP~ was loaded orrto two rlewly prepared coiumrls. The 
flow through (1 " fractiarl) was tested for the preserrce of IPti (phosphate 
determirration experiment) Fifty millilitres of O.050M Hel were then passed 
through the column to elute any poi retained by the resirr The IPo 
carlcentration was determined in the 2"" fractioo 5ml of 2M H,SO. was 
passed through the coli.lmrl to elute IPo IPo was determined in each fraction 
(phosphate determination experiment) and the percentage composition of IP~ 











Results and Discussion 
Table 2.9 shows the amount of IPc, determined in the three fractions collected 
from the column after application of 5 ml of a 5.0 mg~ IPo solution. 
Table 2.9: Application of IPc, standard solution 
E'Uil!~I iI ~\PO~ (AbS~< p~ I~d~glrj' - ->';. " 1P6 compo:L~I.on ~'/~!,D 
, ~.'. ~., _. I," ~ ,. Theoretical Actual ," 






(3.715.0) X 100 
=74% 
97.6 
Since IPs is only 75.8 % pLl'e, the corrected percentage composition is' 
7410.758 
= 97.6% 
Since 5mg of IPs salt contained only 75.8 % IPo, its percentage composition 
after passing through the column was 97.6. 
Condusion 
50 ml 0.05M Hel efficiently separates PO.)' from IP~ and 5ml 2M H2 SO. 
elutes 97.6",t, of the strongly retained IPo ions from the column 
2.4.9 Urine 
A urine sample (24-hr) was obtained from a healthy male subject It was 
filtered through a pre-filter (0.75~m. Macherey-Nagel, Germany) and OA5j.1m 
filter paper (MIII~e Corporation. Bedford). An aliqLKJt of 5 ml was applied to 












Then SO ml of O.OSOM Hel was passed thrOligh the column followed by 
passage ofSml of 20M H,SO • . and each of these two eluates was collected 
Each of the three fractions were analysed for IP" 
In a separate experiment. a second 24"hr LXine sample was collected and 
treated as the one above However, on this occasion the urine was dosed 
wi th a known concentration of IP6 (2\-11 of a 0.7S8 mg~ phytate standard 
solution) in order to test whether the measLXed IP" concentration would be the 
sum of urinary and added IPi concentrations The percentage composit ion of 
the standard solutiOO added was calculated. 
Results and Discussion 
Table 2.10 below shows the results of the application of the method used In 
determining concentralion of phytate in urine using lower Hel and HISO. 
concentrations. 
Table 2.10: Urine sample (Sml) application 
~ Eluate ,\PO.' c\ (Abs) PO, "(mg/l) IPdmg/l) _. 
" 1 Low' - -
2 Low' -
3 028 4,12 1.68 
'below detectable range of s pectrophotometer 
From the phytate caliDration curve (Figure 2.14),0.28 = 03019x - 02284 
0,S084=0.3019x 
x = 1.68 mg/! 
< 
The experimental resul t shows that in the 1" fraction there was virtually no IPo 
as the difference between the unhydrolyzed and hydrolyzed fractions was 
negligiDle, The same observation was made for fraction 2. All of the phytate 











Table 2.11 below shows the reliability arld accuracy of the method developed 
to determirle IPe from urine 
Table 2.11: Applicatiorl of urirle sample dosed with I P, onto the columrl 
Sample IP6 added IP6 (mg/I) 'I. ComposFllorl 
(mg/I) Theoretical Actual 
Urine - 0.96 
Urirle + IP. 0.677 1.40 65.0 65.6 
IP" cOrlcentratlon of the urine increased by 0.44 mgn (1.4 - 0.96) which may 
be attributed to the dose of IPe admirlistered. 
Therefore the percerltage compositiorl IS (0.44/0.677') x 100 '" 65.0% 
After correcting for the percentage composition: 6510.758 = 85.8% 
Conclusion 
The method of indirect extraction/photometry for the determination of IP, in 
urine works efficiently with O.05M Hel and O.2M H,SO. The method 
separates pol- from lPG, albeit rlot perfectly Nevertheless, results are 
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DETERMINATION OF MYOINOSITOL HEXAKISPHOSPHATE (PHYTATE) 
IN URINE 
3.1 Introduction 
IPo IS present in many food substances It is a naturally occurring plant 
constituent and forms 10 - 30 g/kg of the dry matter of cereal. legumes and oil 
seeds (Burbano et aI1995). 
3.1.1 Concentration of IP. in Urine 
The normal concentration of IPo in urine varies between 0.5 and 6.4 mgn 
(Grases and Llobera 1996, March el al 1998) It has been observed that 
recurrent CaOx stone·formers and healthy individuals differ in their 
concentration of IPo (Grases et al 2004). Stone-formers characteristically 
have lower urinary phytate concentratIOns than healthy individuals. The 
average concentration of this substance in healthy individuals' urine is 2.94 ± 
02 mgtl, while in stone-formers it IS 1.13 ± 0 17 mgn (Grases e/ aI2oooa). 
3.1.2 Relationship Between Oral Intake and Urinary Excretion 
The urinary concentration of IPo strictly depends OIl its oral intake (Grases el 
aI2004) Studies have shown that ingestion oIIP.-rich food leads directly to 
an Increase in the urinary excretion of tflis substance Conversely, an IPo-
poor diet causes depletiOO in tfle concentration of this substance in urine 
After conducting a thorough pharmacokinetic prOfile study on IP6. Grases et al 
(2001) showed that the OIlly way to maintain adequate levels of IP6 in humans 
is to supply a healthy IPo-rich diet or IP6 supplements 
In two studies in Which Grases et al used a rat model (2ooob) and humans 
(2001) respectively a mutual relationship between the oral intake and urinary 















































foods (Table 3.1) for their other meals In addition. all candidates were 
required to drink 6 - 8 glasses per day of tap water They were also instructed 
to refrain from eating before breakfast and for one hour thereafter. 24h urines 
were collected during the final day of the protocol 
Table 3.1' Dietal)! instructions 
, 
". " -:.~ 
, ' 
Whole wheat bread White bread 
Durham wheat White bread 
Brown rice White ricelBasmab rice 
Corn chips Potato chips 
Peanuts, cashews, almonds Chocolate 
All Bran flakes Rice Crispies 
Weet-bix Rice Crispies 
Kidney beans Vegetables 
Soya Milk Cows milk (except on 'high phytate day') 
Oats (except oats provided) Rice Crispies 
Legumes (e.g. lentils, beans) Vegetables 
The candidates were required to complete a food dial)! to irldicate their 
ingestion during the three days of the experiment Three candidates from the 
white group were exduded from the study because their diaries recorded that 
they had eaten fibre and phytate-rich food substances (i.e. pro-nutro, muesli 
bar arld peanut butter) duril"lg the IPo-restricted dietal)! period The nutrient 
content of the lPn-rich breakfast is given in Table 3.2. The approval for dietal)! 
studies was obtained from the University of Cape Town 
Means of urinal)! IP" concentrations arld physicochemical parameters were 
statistically analyzed for individual and interactive effects (shown in the 
appendix) by the method of analysis of variance (ANOVA), A probability of 
p < 0.05 was used for assessing statistical sigrlificance at a 95% confidence 
level These values were computed using a two-tailed t-test Average values 












assumption was made that the two groups had equal variances and thus the 
variances were pooled. 
3.3 Results 
Table 3.2: Nutrient COrlterlt of IPo-rich breakfast 
'Variables Mean 
Total Protein (9) 22.3 
Total Fat (g) 27.5 
Total Carbohydrate (g) 116.8 
Fibre (g) 14.4 
Added Sugar (g) 16.0 
Oxalate (mg) 0 
Ca (mg) 329 
Mg (mg) 223 
Phosphate (mg) 787 
K (mg) 831 
Na (mg) 427 
Zrl (mg) 4.97 
Vitamin A (1-19) 160 
Vitamirl 66 (mg) 0.253 
Vitamirl C (mg) 4.0 
Vitamirl D (I-Ig) 0.66 












Figure 31 1 and 3 12 below show the urinary concentration of IP6 ill each 
subject from the two race groups on the IP~- restricted and IP~- rich diets 
Figure 3.1. 1 C~~nU~li"n ", urinary phytaM in black sUbjftcts dunng an 
IP,_",slrlcled and IP,-rlch d,et. 








FOgu" 3.1.2: Coneentroto,," of .. inary ptlylalft in whitft s.ubj<l'Cts ~i"9 an 
















Figu .... 3.2: Ave ... ge concentrations of IP, measured after the black and white 
participants were on IP,_restricted and rich diet. 
The standard error (SE) and p-values obtained when the comparisons are 
made within each race group and when blacks are compared to whites are 
shown in Table 3.3. 
Table 3.3: Comparison of urinary IPs concentrations in black and white 
candidates after following IPs-restricted and IPs-rich diet 
- -- --" -
, . 
• 
BVs B 202:!:0.19 3.21 :!: 0.19 <0.001 
It is noted that there were no inter-group differences which were statistically 












while on the restricted diet (p=Q,Q84) Of interest is the observation that within 
the groups, urinary IPs Increased significantly in blacks but not in whites when 
switdling from the restricted diet to the rich diet 
Figure 3,3 shows the average concentration of IPo in the rural black and urban 
\\Ihite candidates while on their free, unrestricted diets It is noted that the 
black candidates had a statisticaHy significant (p=Q,Q19) lower IPs 












.... _, ._-' 
Figure 3.3: Ruml black (n=ll) and urban white (n~91 candidates' av~rag~ IP, 
concentration while on an unrestricted diet 
Urinary composition data parameters (descriood in the methods section) are 
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Crystallization is a process brought about by deposition of inorganic 
crystalline materials under normal conditions (Hess and Kok 1996). Though 
crystailizatioo occurs in all the body flLids. in urolithiasis research. the focus is 
mainly on studying crystallization of the calcium salts that occurs in the urinary 
tract This process is of paramount importance towards formation of 
calcification (formation of calcium crystals in urine) Formation of crystals in 
urine is often considered to be a physiological event and therefore cannot be 
used 10 distinguish between rlon-slooo formers and the healthy mdlviduals 
(Hess el 8/2001). Urine is always supersaturated wilh CaOx cryslals and to a 
lesser extent wilh Ca3(PO.h and the presence of Ihese crystals in urine is 
referred to as crystalluria (Kavanagh 2001) It is therefore importanlto know 
in detail the sleps leading 10 this process as well as the different aspects 
involved Crystallization is always studied with respect to CaOx, as the latter 
is Ihe most common component of human kidney stones (Egan et aI2004). 
Centrifuged and filtered urine is often used 10 evaluate ill vitro the 
crystallization process of CaOx (Guerra et al 2004) Conditions considered 
favourable to trigger this process include the following; 
• degree of supersaturation of the calcium salts 
• presence of heterogenous nucleants 
• presence and concentration of crystallization irthibilors 
(Grases and Cosla-Bauza 1999) 
Many methods have been employed to study cak::ium oxalate (CaOx) 
crystalhalion (Kavanagh 1992), Different approaches enable distinct types of 
measurements 10 be made and therefore different mechanisms 10 be studied 
The problem, however. is that due to different conditions under which 








































were ..... ..: .... <3 .. 0,; 











Table 4.1: Preparation of NaOx standard solutions 
The calcium oxalate metastable limit of each Urine was measured using the 
method described by Ryall et a/ (1985) Briefly, 10 ml aliquots of urine were 
transferred to thirteen Coulter cups that were incubated in a shaking water 
bath (100 rpm) at 37"C Thereafter, sodium oxalate solutions (1001l1) of 
concentrations IS, 30, 45, 60, 75, 90, 105. 120, 135, 150, 165, 180 and 195 
mM, respecti\lely, were added to the cups 
After a 30 minute incuballon period the number of particles was counted in 
each cup using a Coulter Counter I (Beckmann) fitted with a 140-lJm orifice 
(2.8 - 90.0 Ilm particle size range) A graph of particle number \lersus sooium 












4.2.3 Results and Discussion 
Graphs of particle number versus sodium oxalate cOrlcerltratiorl are showrl irl 
Figure 4 1 and 4 2 for black and white subjects respectively. 
--- _rI 
- - '"I .--
• 
Figure 4.1 . A~elllg~ mat .. t~ble limit exper""ental result (10 black subjects) 
Figure 4 1 ii1dicates that the average metastable limits in the urine of black 
subjects while on IPr,-restricted and IPo-rich diets were 45).1M ai1d 60).lM. 
respectively However. these were not statistically different Nevertheless. 
the urine colJected after the subjects were on the IP~-rich diet tended to show 
a greater resistance to nucleatioo of CaOx crystals and this is ascribed to the 


















The <lver<lge met<lst<lble limit v<llue obtained in the white subjects when 
<In<llysing the urines collected <lfter <ldministratlOn of IPo-restricted and IP6-
rich diet was 15 and 30>IM, respectively. Though these values appear to De 
different, statistic<ll an<llysis reveals that they are not and this is due to the 
large standard deviations Nevertheless, it is noteworthy that 6 out of 7 urines 
had a higher MSL value after the phytate-rich diet 
4.2.4 Conclusion 
It C<ln be seen that MSLs are higher in black sUbjects. Moreover, the average 
increase in MSL after IP6-rich diet appears to be greater in white subjects 
(100% increase) than in bI<lCk subjects (33%). If this change in the MSL can 
be attributed to the ingestion of IP6, it suggests that phytate has a smaller 
effect in black subjects, possibly bec<luse of different renal handling 
mechanisms in this race group recognising that rartdom errors may also 
contribute 
4.3 Sedimentation KinetiCS 
4.3.1 Introduction 
The procedure requires constant stirring of a saturated sll.-ry of COM crystals 
until equiliDrium is established. This is ascertained by measuring the optical 
denSity of the slurry using a spectrophotometer. A constant 00 indicates that 
equilibrium has been achieved Thereafter the stirrer is switched off 
Spontaneous sedimentation of p<lrtlcles then occurs Neither nucleation nor 
growth occurs since the crystals and solution are in eqUilibrium. However. 
crystals which were formerly dispersed throughout the suspension begin to 
<lggreg<lte with one another thereby increasing overall particle size. Since the 
particle are now larger, their rate of sedimentation increases. This manifests 
itself with a concomitant decrease in 00 The sedimentation rate is 
determined by measuring the gradient of a graph of 00 versus time 
corresponding to the period during which the stirrer has been switched off. 
The experiment allows inhibitors III <lliquots of urine to be Introduced into the 
slurry thereby enabling aggregation inhibition to be measured. This is 












ancl a test sample (mhibilor present) and applying them in the following 
equatlorr 
% Inhibition of aggregation = 100 -100(SdST) 
So = gradient of control sampie (00 liS time) 
ST = gradient of test sample (00 liS time) 
4.3.2 Method 
Preparation of COM crystals 
COM crystals were prepared by mixing calcium chloride (10 mM) and sodium 
oxalate (10 mM) solutions at room temperature (solutKlns were made by uSing 
filtered distilied water). The solutions were introdLlCed at a constant speed of 
10 mllmin using a peristaltic pump and the mixture was stirred for a week at 
4°C after which it was filtered using Q.22-\.Im filter paper. The residue was 
wasl1ed with methanol and dried at 9SoC for one hOLir Its composition was 
determined by x-ray powder diffraction (Fig 4.3). 
• . -• '.0Il"'-
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The d spacings and relative intensities for each reflection correspond with the 
standard values for COM (Sutor and Scheidt 1968), Characteristic peaks for 
calcium oxalate dihydrate (COD) and calcium oxalate trihydrate (COT) are 
absent Thus, it is 100% COM 
COM slurries were prepared by adding 40 mg of COM crystals 10 50 ml of 
10mM tris(hydroxymethyl)-amioomethane (Tris)HCI buffer, The latter was 
prepared by dissolVing 079g (10mM) of tris(hydroxymethyl)-aminomethane 
and 2,63 g (90mM) of NaCI in 500 ml of distilled water with stirring The pH of 
the solution was then adjusted to 7.2 using concentrated HC!. 
Slurries were equilibrated overnight (16 hours) in a 37"C water bath under 
constant magnetic stirring (1100 rpm) After eqUilibration, slurries (1,6 ml) 
were incubated for two hours with filtered urine (OA ml) collected after 
candidates were on an IP6-restricted or IP,-rich diet at 37"C, and the mixtures 
were stirred at 1100 rpm for 2 Murs The urine samples were not dialysed 
(although this is prescribed by Hess et a11989) to avoid any possible loss of 
phytate as it is a low molecular weight Inhibitor COM slurries (2.0 ml) were 
used for control experiments. 
After the two hour il"lCubation period, 2 ml aliquots of the crystal-urine slurries 
were transferred into a 10-mm light path glass cuvette in a cell Mlder 
thermostated at 37"C The absorbance was measured using a 
spectrophotometer (Specord 40, United Scientific, Cape Town) interfaced to a 
computer, Each solution was at first stirred slowly until 00510 reac/1ed a 
stable plateau, after which 1t1e stirrer was stopped (indicated by arrows in 
Figure 45) The absorbance readings were measured for 900 seconds The 
same procedure was followed for the control experiment (COM slurry). The 
graph of 0062" against time was plotted 
4.3.3 Results 
Figure 4 4 shows absorbance versus time graphs which were typical for Doth 












(a) urirte from controls, (b) urine collected after IPB-restricted diet and (c) unrte 
collected after IPB-rich diet 
, . 
r 
I .. I I .. 
" 




.. - -" .. '" 
Figure 4.4.1: Typical absorbance"" time graph" observed in the d,fferent sample" 




Figure 4 .•. 2: Typical ab~o,bance vs time graphs observed in the d,fferent samples 













Sedimentation rates and the inhibition of CaOx crystal aggregation were 
calculated from the gradients of the absorbance vs time decline after the 
stirrer was SWitched off Table 4.2 gives results for both groups. 
Table 4.2: Mean percentage (%) inhibition of aggregation 
• IP, .Restricted Diet IP, Rich Dill! " P value 
Black 925 88,1 1.20 "O,019 
Whites 83,1 74.3 5,03 0.230 
black versus white 
I Po-restricted Diet 92,5 (8) 83.1 0N) 3,20 '0.052 
IP~ Rich Diet 88 1 (8) 74.3 (W) 406 ··0026 
• " • W ~ Whit" "" B BI~ G S bJ"GI S ,e , .. 
•• Statistically significant • Approaching significance 
4.3.4 Discussion 
Comparison of the results obtained on both IPo-restricted and I Po-rich diets 
(Table 4,2) shows that the percentage inhibition of aggregation was 
significantly greater in blacks than in whites (p=0.052 and p=O,026 
respectively) Since urinary phytate concentrations between the two groups 
were not significantly different (Table 32), differences in the inhibition of 
aggregation cannot be attributed to this compound In fact. contra-intui~vely, 
urinary IPo concentration tended to be somewhat higher in whites than in 
blacks on the IPo-restricted diet (p=0,084, Table 3,2), The urine composition 
data (Table 3.3) do not provide any clues either, except for a lower lIinary 
oxalate in blacks which tended weakly towards Significance on the restricted 
diet (p=O,085. Table 3,3) However, this IS unlikely to be the key factor The 
conclusion must therefore be that other unidentified factors in the urine of 
black subjects are responsible for providing enhanced protectiol1 agail1st 
caOx crystal aggregatiol1 These factors could be il1herently presel1t il1 the 












diet or they might arise as a consequence of the two dietary protocols. The 
results of the present study are unable to determine which of these 
possibilities is the appropriate one. 
It is noted that relative to the IP6-restricted diet. inhibition decreased 
signiiicantly in black subjects following the administration of the IPo-nch diet 
(p=D,019, Table 4.2) but not in white subjects (p=D.23D, Table 4.2) This 
effect can be attributed to the signifICant increase in urinary oxalate excretion 
observed in this group (p=0,OO3, Table 3.3) 
4.4 "C-Oxalate Deposition Experiment 
4.4.1 Introduction 
According to Grover et .11 (1998) and Aggarwal et .11 (2000), CaOx deposition 
kinetics can be determined in hlJTlan urine by dosing the latter with 
radioactive "C-oxalate 
4.4.2 Method 
30 ml of urine from black (n=4) and white (n=5) was transferred to soda-glass 
bottles and placed in an oven at 37"C 15-~1 14C oxalic acid was added to 
each bottle together with 250 jJl sodium oxalate (15 jJM above the previously 
determined metastable limit) The bot~es were incubated at 37°C for various 
time intervals (0, 30, 60, 90, 120 minutes). Each bottle was shaken 
throughout the incubation period At each time point, 2.5 ml of the sample 
was Withdrawn USing a Gilson pipette and filtered (0.22 ~m) into a Vial 
containing 250 ~I of concentrated HCI to quench the reaction, After shaking 
the vial for about 30 seconds, 1 ml was withdrawn and added to 10 ml of 
scintillation fluid. The experiment was done in duplicate Thereafter the 
samples were ptaced in a scintillation counter and counts per minute of 14C in 












4.4.3 Results and Discussion 
Figures 4.5.1 and 4.5.2 show the typical kinetics for calcium oxalate crystal 
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The graphs show that the amount (expressed as a percentage) of CaOx 
deposited in the urine while the subjects were following IP,-rich diet was lower 
than that on the restricted diet However. statistical evaluation of the results 
at 120 minutes (Table 4.3) shows that no staustically signi ficant differences 
were observed in either group after the subjects had followed both IPG-
restricted and IP6-rich diet nor were there any differences between the groups 
themselves This might be explained by the relatively short duration of IP" 
administration in the present study (3 days). Two previous studies in which 
lower (Grases and Costa-Bauza 1999) and higher (Grases el 211 2001) IP" 
doses were administered, were carried out for 15 and 16 days. respectively. 
In the latter studies, after 36 stone-formers were treated with phytlc acid 
(12Ornglday) for 15 days. it was observed that deposits of CaOx and calcium 
phosphate did not form. According to Grases et al (2001), stone formers 
have low IP6 urinary concentration. Therefore greater inhibi tion might have 
been observed in the present study if the period during which IPo was 
ingested had been lengthened. 
Table 4.3: Average percefltage (%) precipitation of Ca14C-Ox crystals In 
the urine of black (n=4) and white (n=5) subjects at 120 min 
Ef:~::': ~ -IP.-Re.stricte.~ ~iet tP,_Rlch Di .. 1 
, SE ~ p_value"ll 
, , ,~ -;., .~- -"" -"" 
Blacks 32.6 29.2 7,06 0.755 
WMes 23.9 19.4 8.99 0.731 
black versus white 
IP,-Restricted Diet 32.6 (8) 23.9 (W) 9.25 0.554 
IP,-Rich Diet 29.2 (8) 19.4 (W) 8.13 0.450 
• • B Black Subjects. W White Subjects 
For blacks, the rate of deposition after ingestion of IP,-restricted diet and IP,-
rich diet was respectively 0.22 and 0.23 %Imin. For their white counterparts. 
the rate of deposluon of CaOx after IPs-restricted diet was 3.57 %Imirt and 
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GENERAL DISCUSSION AND CONCLUSION 
In Ihis chapter. it is appropriate to assess the extent to which the original 
objectives were achieved 
The first major aim of this project was to design, develop and test an assay to 
measure the concentration of phytate in the urine of healthy black and white 
subjects A considerable proportion of time was spent on attempting to 
achieve this objective using a commercial IP. sodium saiL the purity of which 
was assessed and confirmed using ion chromatography and NMR 
spectroscopy. In order to optimise the recovery of IP", the method of March et 
al (1998) was modified in two ways: firs~y, the use of charcoal to filter the 
urine was omitted and secondly, Hel was not used as a urine preservative. 
Both of these procedures were deemed to be sources of error in that they 
coutd possibly reduce the concentration of IP6. The modified method was 
validated and was shown to be more efficacious than the previously published 
protocol. 
The second objective was to test the hypothesis that the higher dietary intake 
of phytate in the Dlack group leads to r~ativety higher urinary concentrations 
of this substance in this group. Modlin (1981) had previously reported that the 
Dlack group's dietary intake of fibre-rich foods was greater than that of whites 
and this was substantiated by a recent study which showed that the total 
dietary fibre intake of rural black females in South Africa is more than double 
that of their urban counterparts (no avaitaDie data for males) (Vorster and Nell 
2001). Modlin speculated that rural blacks would have higher urinary phytate 
levels than urban whites and that these elevated concentrations contribute to 
the black group's protective mechanism against catcium oxatate stone 
formation. Despite this important hypothesis, he did not measure urinary 
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Candidates' Urinary Composition 
Table 1.1: 10 blact\ sUbfec.ts· IJlIle composition (phytale-restricted dlel) 
S."'pl<" Ii" " " Volume (mll2<l'u) 2430 1800 
" .. , '" SodYJm (mmoIl24~1) 120 1 ,., 
Po\us.um (m~r2'1'f) '" '" 1 1,;.I","m jmmoll24hfi 3 M2 
Mogna.iJm (mmCU24 r) ,~ , .. 
Phosphlle Imm~124 hr) '" ". 
I O.alate (mm~l2.hr) '" 03< I Citrate (rnmo,'24hr) "0 22' 
Un.; acid (mrnC)i/24hr) 3M "0 
Chloride jmrno<'24hr) '" '" R 8rusMe 0.2892 0.8033 
RS Ca~um oulate 6.02U 8.ln4 






























0 ' d 
OS .. 
'''' '" '" ,,. " .. 1~9 7 
". ~. 









" .. .. " 
"'" 1$20 lS10 "" ." '" ... '" 2378 , ... 101 .2 '" ". '" '" ". 
'" '" "" 0.24 ," ... 0.B3 077 
3" ," '" 1~.~ 0", 0" '" 0.20 3.28 3.34 '" '" 
~ " 2.70 t.60 '" '" ". 55.0 1.6218 0.7924 00571 0.0!71 
1."$8 ,og37 05914 1.5905 











Table 1.2: 10 black sub,tect&' urll1e composition (phylale -rich diet) 
s.""", No " " " .. .. .. " " M " Volume (mV24hr) "" " .. '''' "'" "'" "'" " .. "'" ,." "'" ." '" '" ". ", Ii_DO '" '" '" " ", Sodium (fMl0II241'1,) 211i. I .. , 117 2 '" "" , ... ISH 174~ 1439 1355 
Potassium ImmoL'204hrj '" '" m ~, '" ". ... '" 125 ~ ~, Caltlum (""'>C)I'2~t.) ,~ ... "" '" •. '" 3.29 '" ... 0.91 0.79 f.bgr.eoium Immol'24"" ". '" ,,, '" '" '" '" ." ", ". PhO'lp"'l~ (mmoIl24"" ", ". '" ,., '" '" '" ". 27_6 13_3 
OJ<al~ (mmol'2~) '" '" 
,,. 073 '" ". '" '" ''" '" Citrate (fMlOI'24n'l 192 '" 176 '" , .. '" '" '" 1.BJ ". UfO; iIICld (mmoIr ~41'lr') " " " '" " " ., " " '" I erAorid .. ImmoU24rt) '" " m '" '" '" '" '"' '" '" R:. Bru&hte O.1t72 0.1150 0.4500 0.2289 1.020-0 0.3651 0.2129 0.2004 0.2351 0.0933 












Table 1.3: 9 rural 'oIac\(s' urine compO$ltlon (Free diet) 
S~mp/e NO' " .. " .. " .. " .. .. Vaur.e (m1I2.nr) '"'' "''' 1210 '""" ""''' "'" , '"" "'''' ~" 
'" .. , "" '" on "" "" ". 5.65 ,~ SodAlm (mmQ1/2(ftl) "" ~16 6 2851 '" 112 1 1398 1111 "''' '" PoIll$Slunl (mmo1l2( hl) ." , .. 'M' '" ." '" "" '" '" CM.::Ium Imrnol/241W) '" ". '" '" "" 3.(7 "" "" "" Magnetlum (monQl/24twj '" '0> '" '" ... '" '" ,." , .. Pho.phll' (m0\"l0U2.4hrl ,,. '" M' '" " ." 40.5 '" '(' OxioIiI\e Immol/24tv) o.eo ." '" ,~ 0.21 .30 031 ."' '" "'ai, (lmloll24hr) '" 2.21 , . ., '" ,>2 358 '" ". '" Urr;.eod (mI\'\OL'24h'l , .. ". '". '" "" .'" " ,., " CNoroo (mrr0'24tv) , m m 780 ,~ '" "'. '" " RS erU$Mt o 2411 0.1433 0.1134 0.0404 1.4174 0.7858 c .! e47 ccesa 0.1 485 
RS Ca l Cl~m Q"alal8 4.0754 '-8438 2.1441 0.4400 8.55!2 3.5667 M523 3.50011 1.8604 












Tabla 1.4: 7 wMe subjects' urlrte composition (phyta!e-restricted diet) 
!SM1p1t '1a ~ . " G2 , ••. " ' .. "~H" '. ~ ~ .. .. , " . -". . , , Volume rmlr,WIt) '" '" 4650 '" '" 1630 lila 
P" '" ,~ ' M OW '" 6« '" Sodium (mmoL'241YJ 1939 '" "" '" "" 236 . ... oIII5si ..... """ "., '" 158.8 1003 "., 89.1 1124 CalC","" (mmo\l24hr) W '" '" '" '" '" ", MIo\ln",,,,,m (mmoL'24t.-j '" ". ." '" 4.11 '" '" Phosphat. (rrmoll24hr) V ., '" '" '" '" '" '" "late (nYIIO~"24hr ) '" ,.. '" 024 '" O ~ O 0 33 CoI;!Ue (mmoll24llr) '" ' " VI , ~ '" ,.,- '" 'Jnc aCId (mmoIl24hr~ ", '" • . 60 I '"' '" ' " '" ChlonM (nYI"Oli2. hr) '" '" ", '" ,.. '" '" RS Brut n~e 1.(126 2.0606 0.0151 1.2534 O.3)(iG 0.2417 2.3D55 
RS Cil b um O>llat, 1.9089 214155 2.0972 J.5701 1.$719 2.5093 7 .&112 11 











Table 1.5: 7 wtlile $Utljects' urine composition (phylale-rich diel) 
!S~m_No " " " .. OS .. " Volume (niI2~rr) "'" 1310 '" '" '" 1910 1160 .. '" '" '" ". on '" '" SodIum (mrno~""1) '" 1733 201 5 '" 142 1 2092 '" P~",um (mmoll24~I) ." '" '" "., '" 10.1 '" calcoum (mrno\'24tt) W '" '" '" ". '" ... MlIg1e .. um {1IYnOIf24h., "" '" ,~ ,ro ". ." '" 
Pt>:osp~. (mmo(tZ""') ,,, '" m 10.8 389 2M m OxaliICe (mrno\'24hr) , ~ "" ,.'" ,." ." .. , '" Cllfate ( ...... cu.!~h.) ,~ W '" on 1.91 ", .., uroe ~d (mrno\l2~ ,~ S 70 " " "" 3M no .. , (mn'"(llI2 . rrj '" W '" '"' '"' 2" '" RS B.ru$N!! 1.1282 14657 0.9606 0 .14l2 2.3176 0 .250& 1.20 26 
RS !;alCU"n o~~IiI!e 6.1588 5.2378 1.9494 2.9440 2U~91 3.idO 8.1789 












Tilble 1.6 9 Urban wMe re1ildents· (Free diet) 
!~ftT~ N<:t " " . " '" ". " • " .. .. ., Volume (mIrn4Ilr) '" "" '" '" 1280 '" '" '" ." p' '" '" '" f..55 '''' ,., '" ,.~ '" Sod..,m (mmol'24M '" . ,~ , 21107 17~1I 21~ 1 111.3 37.8 '" '" i>rusSlum \rn/'IIOII24ht) ". '" 28.9 ... , '" '" '" " . '" Calc ...... fmmoV24hr) '" '" '" '" '" on '" '" '"' Magnesium \mrnoll2~t-.) ." ,., '" "" ". 2 1S ," '" '" Phc)1P~tle (I'I1moIl24ftr) '" '" '" '" ". '" '" '" '" Ol<lllla!e (mmol124lwJ 03. '" '" '" '" '" ,u '" '" Clr8le (mmoli241T) '" '" '" '" '" '" ". '" 1.07 I..Irie 'eid (mmoIi24nt) '" '''' '" "" "" '" , ., '" '" Ch10nde (mI'M1I24/lfl '" '" '" '" '" "" " '" '" RS 8ru,r-;~ 0.8275 0.7480 05995 0,$.492 0.91 119 • " 0,325$ 1.8151 D. lO!16 RS C~eJum ~x.LIot~ 7.0325 5.5408 5,1275 5,45!lo4 .3150 814118 10.4&07 11.0 i l J .J J7 













Individual Metastable Limit Experimental Results 
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Table 2.1: Black subjects' metastable limit concentrations 
$U-bjeC~ Metastable limit Concentration (mM) .~ • 
0/ ". -" . 
IP, -restrjcted Diet IP, -rich Diet 
01 60 60 
02 60 75 
03 60 75 
04 105 135 
05 90 45 
06 90 105 
07 45 60 
08 45 75 
09 105 135 












Table 2.2: Average particle number at different sodium oxalate concentrations 
in urine of black subjects (noo 10) 
TConcentration (mM) IP,·Restrfcted Diet IP. ·Rlch Diet 
15 786 918 
30 883 998 
45 1837 1109 
60 3935 1716 
75 4884 3018 
00 5867 5989 
105 7663 11019 
120 12768 12431 
135 14129 11731 
150 13926 11524 
165 15414 11592 
180 15384 15335 
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Table 2.3: White Subjects· Metastable Limit Experimental results 
Subject Metastable Ltlnil Concentration (mM) 
IP ..... e$tricted Diet IP, -tich Diet 
01 30 30 
02 30 45 
03 45 45 
04 45 135 
05 45 60 
06 60 75 













Table 2.4 Average particle numoer at different sodium oxalate concentrations 
in urine samples of white subjects (n '" 10) 
Concentration (mM) lPG-restricted Diet lPG-Rich Diet 
15 113 1232 
30 1374 2137 
45 2213 5875 
60 4227 6981 
75 5243 7158 
90 7243 10454 
105 8423 11672 
120 12004 12578 
135 11438 13534 
150 13341 15511 
165 15307 14416 
180 15241 16377 













Sedimentation Experimental Graphs 

















Fig. 3.1: Black subjects' sedimentation results 
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Fig. 3.2' White subjects' sedimentation results 
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Individual 14C_Oxalate Deposition Experimental 
Results 
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Fig 4 2.3 
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